A Randomized, Open-label, Single Dose, Crossover Clinical Trial to Compare the Safety and Pharmacokinetics of YHP1604 in Comparison to the Co-administration of Telmisartan/Amlodipine and Rosuvastatin in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 19 Jul 2017
At a glance
- Drugs Amlodipine/rosuvastatin/telmisartan (Primary) ; Amlodipine/telmisartan; Rosuvastatin
- Indications Hyperlipidaemia; Hypertension
- Focus Pharmacokinetics
- Sponsors Yuhan
- 12 Jul 2017 Planned End Date changed from 1 Aug 2017 to 1 Dec 2017.
- 12 Jul 2017 Planned primary completion date changed from 1 Aug 2017 to 1 Dec 2017.
- 12 Jul 2017 Status changed from not yet recruiting to recruiting.